Biopharmaceutical fermentation systems are specialized equipment and processes used to cultivate microorganisms or cells for the production of biopharmaceuticals. Biopharmaceutical fermentation systems are critical in scaling up from laboratory research to commercial production, enabling the efficient and safe manufacture of complex biopharmaceutical products.
The biopharmaceutical fermentation systems market consists of sales, by entities (organizations, sole traders and partnerships), of biopharmaceutical fermentation systems that are used in the production of a wide range of biologic drugs and therapies.
The global biopharmaceutical fermentation systems market was valued at $14,930.9 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 8.0%.
Rise In Development Of Novel Biologics
During the historic period, the rise in development of novel biologics supported the growth of the biopharmaceutical fermentation systems market. The rise in development of novel biologics can be attributed to advancements in biotechnology, increased understanding of disease mechanisms and the demand for targeted and personalized therapies. Biopharmaceutical fermentation systems are used in biologics production to cultivate genetically engineered cells or microorganisms, enabling the synthesis of complex therapeutic proteins, antibodies and vaccines on a large scale. For instance, according to the National Library of Medicine, a US-based medical library, in 2023, the US Food and Drug Administration (FDA) approved 55 new drugs, including 29 new chemical entities (NCEs) and 25 new biological entities (NBEs), marking a 50% increase compared to the 37 approvals in 2022. Therefore, the rise in development of novel biologics drove the growth of the biopharmaceutical fermentation systems market.
New Technology Development Centers To Enhance Fermentation Capabilities
Companies in the biopharmaceutical fermentation systems market are developing new technology development centers to enhance fermentation capabilities. These centers facilitate the development of more effective and tailored fermentation technologies, thereby improving product development and manufacturing processes. For instance, in July 2023, Praj HiPurity Systems, an India-based company that provides end-to-end turnkey solutions for the biopharma industry, announced plans to establish a Technology Development Center to advance its fermentation technology capabilities. This initiative is driven by the growing demand for fermentation-based products in the pharmaceutical and biopharmaceutical industries. The center will focus on addressing customer challenges, especially in the complex injectable segment and will work on optimizing fermentation solutions to better meet industry needs.
The global biopharmaceutical fermentation systems market is fairly fragmented, with a large number of small players operating in the market. The top ten competitors in the market made up to 20.70% of the total market in 2023.
Biopharmaceutical Fermentation Systems Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global biopharmaceutical fermentation systems market as it emerges from the COVID-19 shut down.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest-growing market for biopharmaceutical fermentation systems? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The biopharmaceutical fermentation systems market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider biopharmaceutical fermentation systems market; and compares it with other markets.
The report covers the following chapters
- Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by application and by end-users.
- Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
- Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the biopharmaceutical fermentation systems market.
- Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
- Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
- Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by product, by application and by end-users in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
- Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
- Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
- Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
- Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
- Competitive Dashboard- Briefs on competitive dashboard of major players.
- Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
- Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
- Conclusions And Recommendations- This section includes recommendations for biopharmaceutical fermentation systems providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
- Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
- 1) By Product: Upstream Products; Downstream Products
- 2) By Application: Recombinant Proteins; Monoclonal Antibodies; Antibiotics; Probiotics And Other Applications
- 3) By End-User: Biopharmaceutical Companies; Contract Manufacturing Organizations; Contract Research Organizations; Academic Research Institutes; Other End-Users
- Companies Mentioned: Danaher Corporation; Thermo Fisher Scientific Inc.; F. Hoffmann-La Roche Ltd.; Sartorius Stedim Biotech; Getinge Group
- Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time-series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; biopharmaceutical fermentation systems indicators comparison.
- Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.